Ghai Jyotsna 4
4 · Singular Genomics Systems, Inc. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
Ghai Jyotsna
Chief Operating Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-10-02−1,666→ 5,000 total→ Common Stock (1,666 underlying) - Exercise/Conversion
Common Stock
2024-10-02+1,666→ 2,266 total
Footnotes (4)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On June 26, 2024, the Issuer effected a 1-for-30 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 has been adjusted to reflect the Reverse Stock Split.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F4]25% of the RSUs vested on October 2, 2024; the remainder of the RSUs vest in 12 equal quarterly installments thereafter, beginning on January 2, 2025.